Assessing How Consumers Interpret, Act on Results From At-Home COVID-19 Self-test Kits

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 31, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.8075?guestAccessKey=82c67492-522d-4712-b6ae-1e904ef9aee9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=013122

 

What The Study Did: This randomized clinical trial assessed how the instructions and results of at-home COVID-19 self-tests are interpreted and whether users appropriately quarantine per federal recommendations.

Authors: Steven Woloshin, M.D., M.S., of the Dartmouth Institute for Health Policy and Clinical Practice in Lebanon, New Hampshire, is the corresponding author.

 

(doi:10.1001/jamainternmed.2021.8075)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.